within the transplant group intravenous acyclovir 5 mg/kg twice daily given throughout the period of granulocytopenia completely prevented oropharyngeal herpes simplex virus infection compared with a 50 % incidence in the placebo arm ( p = 0.033 ) .
C0001367
acyclovir
C0019348
herpes simplex virus